Neuronetics Inc (STIM)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $120.60M
Last updated: Nov 17, 2026 at 4:41 PM ET
Neuronetics Inc (STIM) Stock Chart
Neuronetics (STIM) has a latest price of $1.28 on Nov 17, 2026, 62.8% below its 52-week high of $3.44. Its price fell 35.7% over the past 12 months. The month-end price fell 91.5% since Jun 2018, a compound annual decline of 25.7%.
Price Chart
From Jun 2018 to Oct 2026, its highest month-end close was $33.05 in Aug 2018 and its lowest $0.76 in Sep 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart STIM with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for STIM.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 59.2%, and over 6 months it rose 8.5%. The month-end price rose 95.7% over the 3 years through Oct 2026, a compound annual rate of 25.1%.
| Period | Change |
|---|---|
| 1 month | -33.0% |
| 3 months | -59.2% |
| 6 months | +8.5% |
| 12 months | -35.7% |
| 12 months, with dividends | -35.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +95.7% | +25.1% |
| 5 years | -56.7% | -15.4% |
| Since Jun 2018 | -91.5% | -25.7% |
Price by Year
Its best calendar year was 2020, when the price rose 147.4%, and its weakest was 2019, when it fell 76.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $2.25 | +63.0% |
| 2025 | $1.38 | -14.3% |
| 2024 | $1.61 | -44.5% |
| 2023 | $2.90 | -57.8% |
| 2022 | $6.87 | +54.0% |
| 2021 | $4.46 | -59.9% |
| 2020 | $11.11 | +147.4% |
| 2019 | $4.49 | -76.8% |
Trading Range
The price is 43.9% below its 50-day average of $2.28 and 31.3% below its 200-day average of $1.86.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.28 | |
| 52-week high | $3.44 | -62.8% |
| 52-week low | $0.80 | +60.0% |
| 50-day average | $2.28 | -43.9% |
| 200-day average | $1.86 | -31.3% |
Price Risk
Over 3 years, its largest fall from a peak was 87.3%.
| Measure | Value |
|---|---|
| 1-year beta | 2.10 |
| Largest fall, 1 year | -62.1% |
| Largest fall, 3 years | -87.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About STIM
What is STIM's 1-year price change?
Neuronetics's price fell 35.7% over the past 12 months. With dividends included, the 12-month total return was -35.7%.
What is STIM's 5-year price change?
Neuronetics's month-end price fell 56.7% over the 5 years through Oct 2026, a compound annual decline of 15.4%. These figures leave out dividends.
What is STIM's 52-week high and low?
Neuronetics's 52-week high is $3.44 and its 52-week low is $0.80. Its latest price of $1.28 on Nov 17, 2026 is 62.8% below the high.
What is STIM's beta?
Neuronetics's 1-year beta against the S&P 500 is 2.10, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 62.1%.
Is the STIM chart free?
Yes. Advanced Charting for STIM is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
STIM pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts